Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Funder

Showing results (181-190 of 356) with videos related to

Pageof 36
Sort By:
Molecular and Cellular Endocrinology|August 4, 1999
Androgen stimulates mitogen-activated protein kinase in human breast cancer cellsX Zhu, H Li, J P Liu, et al.
Cardiovascular Research|November 1, 1977
Arterial glucocorticoid receptors: the binding of tritiated dexamethasone in rabbit aortaD Duval, J W Funder, M A Devynck, et al.
Endocrinology|May 1, 1979
The mineralocorticoid antagonist activity of an 11 beta,18-oxidopregnaneS Ulick, D Marver, W R Adam, et al.
Neuroendocrinology|August 1, 1989
Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. 1. In vitro studiesM Familari, A I Smith, R Smith, et al.
The Journal of Clinical Investigation|September 1, 1983
Defective nuclear accumulation of androgen receptors in disorders of sexual differentiationS Gyorki, G L Warne, B A Khalid, et al.
Journal of Hypertension|December 1, 1984
Overlapping but not identical protein synthetic domains in cardiovascular cells in response to glucocorticoid hormonesN R Nichols, M McNally, J H Campbell, et al.
Science (New York, N.Y.)|October 28, 1988
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediatedJ W Funder, P T Pearce, R Smith, et al.
European Journal of Pharmacology|May 1, 1978
Investigation of cardiac beta-adrenoceptors using 125I-labelled 1-(4-iodophenoxy)-3-isopropylaminopropan-2-olE A Woodcock, A Bobik, J W Funder, et al.
Clinical Endocrinology|October 1, 1985
In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assayD Armanini, I Karbowiak, A Goi, et al.
Clinical Endocrinology|April 1, 1983
Cystic fibrosis and normal fibroblasts have identical glucocorticoid receptor profiles and induced protein responsesB A Khalid, S Gyorki, G L Warne, et al.
Pageof 36

Showing results (181-190 of 356) with videos related to

Sort By:
Pageof 36
Molecular and Cellular Endocrinology|August 4, 1999
Androgen stimulates mitogen-activated protein kinase in human breast cancer cellsX Zhu, H Li, J P Liu, et al.
Cardiovascular Research|November 1, 1977
Arterial glucocorticoid receptors: the binding of tritiated dexamethasone in rabbit aortaD Duval, J W Funder, M A Devynck, et al.
Endocrinology|May 1, 1979
The mineralocorticoid antagonist activity of an 11 beta,18-oxidopregnaneS Ulick, D Marver, W R Adam, et al.
Neuroendocrinology|August 1, 1989
Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. 1. In vitro studiesM Familari, A I Smith, R Smith, et al.
The Journal of Clinical Investigation|September 1, 1983
Defective nuclear accumulation of androgen receptors in disorders of sexual differentiationS Gyorki, G L Warne, B A Khalid, et al.
Journal of Hypertension|December 1, 1984
Overlapping but not identical protein synthetic domains in cardiovascular cells in response to glucocorticoid hormonesN R Nichols, M McNally, J H Campbell, et al.
Science (New York, N.Y.)|October 28, 1988
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediatedJ W Funder, P T Pearce, R Smith, et al.
European Journal of Pharmacology|May 1, 1978
Investigation of cardiac beta-adrenoceptors using 125I-labelled 1-(4-iodophenoxy)-3-isopropylaminopropan-2-olE A Woodcock, A Bobik, J W Funder, et al.
Clinical Endocrinology|October 1, 1985
In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assayD Armanini, I Karbowiak, A Goi, et al.
Clinical Endocrinology|April 1, 1983
Cystic fibrosis and normal fibroblasts have identical glucocorticoid receptor profiles and induced protein responsesB A Khalid, S Gyorki, G L Warne, et al.
Pageof 36